Joe Biden tests positive for Covid-19 again3 min read
Biden has experienced “no reemergence of symptoms, and continues to feel quite well” and will, as a result, not resume treatment, the White House said. O’Connor said the President tested negative on Tuesday evening, Wednesday morning, Thursday morning and Friday morning before testing positive on Saturday morning.
“However, given his positive antigen test, he will reinitiate strict isolation procedures,” the doctor noted. Biden ceased isolating on Wednesday after testing negative on successive antigen tests, celebrating his return in remarks from the White House Rose Garden.
A White House official said contact tracing efforts were underway Saturday after Biden’s positive Covid-19 test.
The President had resumed events at the White House after testing negative this week, though he was seen wearing a mask more regularly. White House officials said they worked to ensure there was social distancing at the public events he held at the White House.
When Biden first tested positive last week, the White House said he’d had 17 close contacts, none of whom ended up testing positive themselves.
First lady Jill Biden remains in Delaware, where she has been since the President first tested positive for Covid-19, a White House official told CNN. She has not been back to the White House.
The first lady had been scheduled to join the President when he traveled to Wilmington on Sunday.
Biden is fully vaccinated and received two booster shots. He received his first two doses of the Pfizer/BioNTech Covid-19 vaccine ahead of his inauguration in January 2021, his first booster shot in September and his second booster vaccination in March.
White House officials had previously suggested a rebound case of Covid was unlikely, based on reports of cases around the country. However, Biden continued to be tested and monitored.
Infectious disease experts have been calling on the government to study instances of rebound more systematically, saying the phenomenon needs to be better characterized to understand who is most at risk and whether the standard five-day course of treatment with the drug should be lengthened to prevent it. Studies have shown that people can pass the infection to others during a rebound, which is another reason to better understand it.
Pfizer, the company that makes Paxlovid, has said its studies show rebounds are rare and happen in people who take the drug as well as those who took a placebo pill. Because investigators noted the phenomenon in both groups, the company doesn’t believe it is tied to the medication.
This story has been updated with additional developments.
CNN’s Kate Bennett, Brenda Goodman, Virginia Langmaid and Jamie Gumbrecht contributed to this report.